Global Biologics Outsourcing Market Analysis, Size, Share, Growth, Trends & Forecast 2016-2024 - ResearchAndMarkets.com

DUBLIN--()--The "Biologics Outsourcing Market by Product , by Type , by Sources and for Applications : Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024" report has been added to ResearchAndMarkets.com's offering.

In global biologics outsourcing market, the biologics are expected to be a significant area of growth, however, they are starting from a lower base and there is a greater bias against outsourcing biologics production. Outsourcing is increasing as a percentage of the whole manufacturing capacity due to relatively more of new product manufacturing is outsourced and facilities with products that become generic are non-core and are being divested.

The global biologics outsourcing market was valued at around USD 8,420.0 million in the year 2016 and it is expected to reach approximately USD 32,000.0 million by 2024. The global biologics outsourcing market is expected to grow at a CAGR of over 18.0% between 2017-2024.

The major factor driving the growth of biologics outsourcing market is the increasing investments in research development of biologic drugs. Because of the facilities with products that become generic are non-core and are being divested and relatively more of new product manufacturing is outsourced the outsourcing is increasing as a percentage of the whole manufacturing capacity. Using a third-party manufacturer can act as an additional site in a multiple site supply strategy, provide backup capacity and increased supply security.

Industry Players:

  • Boehringer Ingelheim GmbH
  • Catalent, Inc.
  • GenScript
  • Innovent Biologics, Inc.
  • Syngene
  • Shanghai Medicilon inc.
  • GL Biochem Corporation Ltd.
  • GVK Biosciences Private Limited
  • Horizon Discovery Group plc.
  • Innovent Biologics, Inc.
  • Selexis SA
  • Lonza
  • Abzena Plc
  • Adimab LLC.

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Biologics outsourcing Market Dynamics

4. Global Biologics outsourcing Market Competitive Landscape

5. Global Biologics outsourcing Market Product Segment Analysis

6. Global Biologics outsourcing Market Type Segment Analysis

7. Global Biologics outsourcing Market Source Segment Analysis

8. Global Biologics outsourcing Market Application Segment Analysis

9. Global Biologics outsourcing Market Regional Segment Analysis

10. Company Profile

For more information about this report visit https://www.researchandmarkets.com/research/l5gkhv/global_biologics?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biopharmaceuticals , Pharmaceutical Manufacturing

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biopharmaceuticals , Pharmaceutical Manufacturing